Tessa Romero

Stock Analyst at JP Morgan

(4.28)
# 443
Out of 5,042 analysts
64
Total ratings
48%
Success rate
22.01%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tessa Romero

ACADIA Pharmaceuticals
Sep 29, 2025
Maintains: Overweight
Price Target: $34$33
Current: $22.02
Upside: +49.86%
Neumora Therapeutics
Sep 16, 2025
Downgrades: Underweight
Price Target: n/a
Current: $2.63
Upside: -
Edgewise Therapeutics
Aug 19, 2025
Maintains: Overweight
Price Target: $40$30
Current: $15.18
Upside: +97.63%
Dyne Therapeutics
Jul 15, 2025
Maintains: Neutral
Price Target: $10$9
Current: $17.12
Upside: -47.43%
Biohaven
Jun 18, 2025
Maintains: Overweight
Price Target: $68$55
Current: $16.60
Upside: +231.33%
Cytokinetics
Jun 9, 2025
Maintains: Overweight
Price Target: $71$53
Current: $57.83
Upside: -8.35%
Lexeo Therapeutics
May 30, 2025
Maintains: Overweight
Price Target: $16$10
Current: $9.23
Upside: +8.34%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $38
Current: $21.85
Upside: +73.91%
Seres Therapeutics
Oct 24, 2024
Downgrades: Underweight
Price Target: n/a
Current: $17.85
Upside: -
Scholar Rock Holding
Oct 14, 2024
Maintains: Overweight
Price Target: $18$31
Current: $29.68
Upside: +4.45%
Maintains: Overweight
Price Target: $32$29
Current: $11.98
Upside: +142.07%
Reinstates: Neutral
Price Target: $46
Current: $43.33
Upside: +6.16%
Maintains: Overweight
Price Target: $54$55
Current: $40.76
Upside: +34.94%